![](https://pda.org/images/default-source/default-album/eu-training-courses/2024/eu-tc-banner-general.jpg?sfvrsn=b0aec39b_4)
PDA EU00007 Extractables and Leachables
Registration Options
Individual Registration
Group Registration
Program Highlights
This training course will look at Extractables and Leachables from many different angles: definitions, regulations, material and polymer science, analytical E/L methodologies, safety assessments, and study design for different parenteral primary packaging systems and injection devices.
When making parenteral drug products, pharmaceutical companies are faced with the need to further investigate the materials that will be in contact with the drug product, either during manufacturing, intermediate storage, storage in its final packaging, or during the delivery of the drug to the patient. While historically, the potential safety issues were the main driver in these kinds of investigations, recently, quality issues (i.e. for biopharmaceuticals) have also become a concern.
This training course will look at Extractables & Leachables from many different angles, including, Definitions, Regulatory, Material & Polymer Science, Analytical E/L Methodologies, Safety Assessments, and Study Design for different parenteral primary packaging systems and injection devices.
A full session will be dedicated to an in-depth update on regulations, standards, and recommendations in this field (PQRI, USP, ISO 10993, BPOG).
Who Should Attend
- Pharmaceutical Packaging and Device Engineers
- Production Engineers, using SU systems
- Regulatory Affairs Officers
- Pharmaceutical R & D Managers
- Analytical Chemists, working on E/L
- Quality Assurance Officers
Learning Objectives
Upon completion of this training course, you will be able to:
- Explain in detail the current regulatory requirements for container/closure qualification form an E/L perspective.
- Explain the upcoming changes in regulations, standards and recommendations from PQRI, USP and BPOG and how these changes could impact a future evaluation of a pharmaceutical C/C-system.
- Understand the materials of construction, including composition, of container closure systems, and how they could impact the safety and quality of a parenteral drug product.
- Put together an evaluation program (review of provided documentation, analytical testing) of different types of parenteral drug product container/closure systems.
- Perform a safety/risk assessment of analytical results, obtained after completion of an E/L study
Contact
Program Inquiries
Exhibition/Sponsorship Inquiries
Training Course Inquiries
Registration Customer Care
Standard Registration
Member Price
€ 2.200Non-Member
€ 2.200
ALL PRICES IN EURO (EUR), EXCLUDING VAT.
WAYS TO REGISTER: 1. Online Registration 2. registration-europe@pda.org
PDA MEMBERS: Please remember to log in before registering If you come from a Governmental or Health Authority Institution or from an Academic Organization, please contact registration-europe@pda.org before registering.
If you need to apply for a visa to enter the event country, PDA Europe must be informed of this fact at least 4 weeks before the start of the event.
Day 1
Thursday, 27 March 2025
09:00
Introduction and Attendee Expectations
09:15
Introduction on Extractables & Leachables (E/L)
- What is the importance of a good E/L-qualification?
- Historical cases of leachables, impacting the quality or the safety of a drug product
- Regulatory requirements (FDA, EMA…) for primary packaging
10:30
Coffee Break
10:45
Understanding the Materials, Used in the Manufacture of Pharmaceutical Containers & Closures
- Types of polymers – examples in medical/pharmaceutical use
- Understanding the composition of polymers: Intentionally added & Non-Intentionally added Compounds: Their function and origin
- The issues with glass in parenteral applications
11:30
The Mechanism of Leaching
- What are the physicochemical parameters to be considered when trying to understand polymer migration
- How do leachables move through a polymer, the diffusion model
- Special cases in migration
12:00
Lunch Break
13:00
How to Set-up Extractables & Leachables Studies Pharmaceutical Container Closure Systems
- Selecting the right conditions for extraction
- How to select the right compounds to monitor in a leachable study
- Designing a leachable study
14:45
Coffee Break
15:00
Analytical Techniques to Perform Extractables & Leachables Research
- The importance of sample preparation: the corner stone in E/L research
- What are the target compounds for material research
- How does a classification of these compounds assist in finding the right analytical technique
- From basic “screening” methodologies to state-of-the-art equipment
15:45
How to Perform a Safety Evaluation – Risk Assessment on Extractables & Leachables
- Toxicology 101
- EMA Guideline on Genotoxic Impurities
- ICH M7 (DNA reactive Impurities) and its suggested staged approach
- The Threshold Concept of PQRI (OINDP and PDP/ODP)
- Examples
17:00
End of Training Course Day 1
Day 2
Friday, 28 March 2025
08:30
Recap Day 1
08:45
E/L Testing for a Small Volume Parenteral Container Closure systems
- Glass Syringes: the issues with tungsten, glue residues and silicone oil and glass metals leaching
- The Issue with rubbers: the plunger, the needle shield or the tip cap: different approaches needed?
- The impact of secondary packaging – option or necessity?
- Setting up extractable & leachable studies for a pre-filled Syringe
- Biological Drug Products versus Small Molecule Drug Products
- Primary packaging for the lyophilized drug product – modus of interaction with the DP
- Critical aspects when designing leachable studies for lyophilized DP
- Reactivity Of Leachables: concern for Lyophized drug Products
- Integration of the administration procedure (e.g. IV-set, pump system) in leachables evaluation
10:00
Coffee Break
10:15
E/L Testing for Disposable and Single-Use Systems in Bioproduction
- How to classify the risk of different single-use systems in the bioproduction process?
- Understanding BPSA & BPOG recommendations, and how they can be implemented in the study design
- Performing E/L studies on filters: potential approaches
11:00
Large Volume Parenterals
- The challenge in E/L testing for LVP’s
- Primary packaging for LVP’s – critical materials and components
- Secondary packaging for LVP: critical points to consider
11:30
Lunch Break
12:30
Qualification of Injection Devices used for Parenteral Administrations
- Short introduction into Medical Device Regulations (ISO 10993 series)
- Difference in Approaches for Medical Devices, compared to Pharmaceutical Packaging
- Considerations for Combination Products: how to proceed?
14:00
Coffee Break
14:15
Updates of E/L- Regulations, Standards and Recommendations
- Pharma Packaging:
o Final PQRI recommendations of the Parenteral Drug Product (DPD) Chemistry group
o USP <661> & USP<665> chapters: where are we, where could it go to? - (Bio)Pharmaceutical Manufacturing
o The BPOG protocol
15:45
Q&A
16:00
End of Training Course
Featured Trainers
-
Dries Cardoen, PhD
Nelson Labs
Read BioDries Cardoen, PhD
Nelson Labs
Dries Cardoen received his Ph.D. from the Faculty of Biology at the University of Leuven (Belgium) in 2011. After his academic career as a post-doctoral researcher, he started at Nelson Labs (formerly Toxikon Europe) in 2013 as study director in the Extractables & Leachables Department. From the start, he specialized in E&L projects of inhalation drug products. He is currently leading the team of study directors that is specialized in E&L testing of inhalation drug products and topical and transdermal drug products.
-
Piet Christiaens, PhD
Nelson Labs NV
Read BioPiet Christiaens, PhD
Nelson Labs NV
Piet Christiaens received his Ph.D. from the Analytical Chemistry Department of the University of Leuven (Belgium) in 1991. From 1992 to 1997, he was Lab Manager in two Analytical Contract Laboratories. From 1997 to 2000, he worked as an independent consultant with Shell Chemical Company in Houston, TX (US), where he conducted research on a new hydrogenation catalyst system for Hydrogenated Triblock Co-polymers (Kraton Polymers).
From 2001 onwards, Dr. Christiaens holds the position of Scientific Director at Nelson Labs (formerly Toxikon Europe) where he developed analytical methods and protocols for both extractables and leachables studies for the Medical and Pharmaceutical Industries. In addition, he is also leading the R&D department at Nelson Labs, with a focus on understanding the interactions and chemistry of extractables and leachables and developing state-of-the-art analytical methodologies. In the last decade, Dr. Christiaens has been a speaker on the subject of “extractables and leachables” at over 150 Conferences, and since 2014, he has been engaged in the two-day Extractables and Leachables training courses that are hosted by PDA across the Globe. In his current role at Nelson Labs Europe, Dr. Christiaens supports the Strategy and Global Business Development for Extractables and Leachables Service Offerings for Pharmaceutical and Medical Applications.
-
Dennis Jenke, PhD
Triad Scientific Solutions
Read BioDennis Jenke, PhD
Triad Scientific Solutions
Dennis Jenke is the Chief Executive Scientist for Triad Scientific Solutions, a provider of science-based solutions to plastic/product compatibility challenges associated with packaging, manufacturing equipment and delivery devices in the pharmaceutical, cosmetic, food and related industries. He was a Distinguished Scientist at Baxter Healthcare Corporation where for more than three decades he lead a team whose primary responsibility includes the assessment of material/product compatibility, specifically with respect to establishing the suitability for use of packaging systems, manufacturing systems and administration devices for pharmaceutical products (for example, extractables/leachables and product ingredient binding).
He has published extensively in the areas of analytical chemistry, environmental science and material/solution compatibility and serves as an expert reviewer for numerous pharmaceutical and analytical journals. He is the author of the book Compatibility of Pharmaceutical Solutions and Contact Materials; Safety Considerations Associated with Extractables and Leachables and a contributing author to the Leachables and Extractables Handbook. Dennis Jenke is a member of numerous industry groups whose charter is to establish best demonstrated practices in the area of material/solution compatibility.
Become a Sponsor
Interested in becoming a sponsor? Learn about opportunities and benefits.
Request InformationBecome an Exhibitor
Interested in becoming an exhibitor? Learn about opportunities and benefits.
Request InformationPLEASE READ PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.